Ocugen (OCGN) Stock Forecast, Price Target & Predictions
OCGN Stock Forecast
Ocugen stock forecast is as follows: an average price target of $5.00 (represents a 448.73% upside from OCGN’s last price of $0.91) and a rating consensus of 'Buy', based on 6 wall street analysts offering a 1-year stock forecast.
OCGN Price Target
The average price target for Ocugen (OCGN) is $5.00 based on 1-year price targets from 6 Wall Street analysts in the past 3 months, with a price target range of $6.00 to $3.50. This represents a potential 448.73% upside from OCGN's last price of $0.91.
OCGN Analyst Ratings
According to 6 Wall Street analysts, Ocugen's rating consensus is 'Buy'. The analyst rating breakdown for OCGN stock is 0 'Strong Buy' (0.00%), 6 'Buy' (100.00%), 0 'Hold' (0.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
Ocugen Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Aug 23, 2022 | Uy Ear | Mizuho Securities | $5.00 | $2.34 | 113.68% | 448.73% |
| Aug 15, 2022 | - | H.C. Wainwright | $6.00 | $2.88 | 108.33% | 558.47% |
| Jun 18, 2022 | Jennifer Kim | Cantor Fitzgerald | $4.50 | $2.16 | 108.33% | 393.85% |
| May 08, 2022 | Daniil Gataulin | Chardan Capital | $3.50 | $2.16 | 62.04% | 284.11% |
| Apr 25, 2022 | Zegbeh Jallah | Roth Capital | $6.00 | $2.40 | 150.00% | 558.47% |
The latest Ocugen stock forecast, released on Aug 23, 2022 by Uy Ear from Mizuho Securities, set a price target of $5.00, which represents a 113.68% increase from the stock price at the time of the forecast ($2.34), and a 448.73% increase from OCGN last price ($0.91).
Ocugen Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | - | - |
| Avg Price Target | - | - | - |
| Last Closing Price | $0.91 | $0.91 | $0.91 |
| Upside/Downside | -100.00% | -100.00% | -100.00% |
In the current month, the average price target of Ocugen stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Ocugen's last price of $0.91. This month's average price target is down NaN% compared to last quarter, and down NaN% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Oct 15, 2024 | Maxim Group | - | Buy | Initialise |
| May 15, 2024 | H.C. Wainwright | Buy | Buy | Hold |
| Mar 01, 2023 | Cowen & Co. | - | Outperform | Initialise |
| Jun 18, 2022 | Cantor Fitzgerald | Overweight | Overweight | Initialise |
| Apr 25, 2022 | Roth Capital | Buy | Buy | Hold |
| Jun 07, 2021 | Roth Capital | Buy | Buy | Hold |
| Feb 27, 2021 | H.C. Wainwright | Buy | Buy | Upgrade |
| Feb 09, 2021 | Chardan Capital | - | Buy | Downgrade |
| Feb 08, 2021 | Cantor Fitzgerald | Overweight | Overweight | Hold |
| Feb 06, 2021 | H.C. Wainwright | - | Buy | Upgrade |
Ocugen's last stock rating was published by Maxim Group on Oct 15, 2024. The company Initialise its OCGN rating from "null" to "Buy".
Ocugen Financial Forecast
Ocugen Revenue Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Dec 22 | Mar 22 | Mar 21 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - |
| Avg Forecast | $1.14M | $1.14M | $1.14M | $1.14M | $400.00K | $400.00K | $1.14M | $2.17M | $13.87M | $39.04M |
| High Forecast | $1.14M | $1.14M | $1.14M | $1.14M | $400.00K | $421.05K | $1.14M | $2.17M | $13.87M | $39.04M |
| Low Forecast | $1.14M | $1.14M | $1.14M | $1.14M | $400.00K | $385.96K | $1.14M | $2.17M | $13.87M | $39.04M |
| # Analysts | 1 | 1 | 1 | 1 | 1 | 4 | 1 | 1 | 1 | 1 |
| Surprise % | - | - | - | - | - | - | - | - | - | - |
Ocugen's average Quarter revenue forecast for undefined based on undefined analysts is $NaN, with a low forecast of $NaN, and a high forecast of $NaN. OCGN's average Quarter revenue forecast represents a NaN% decrease compared to the company's last Quarter revenue of $NaN (undefined).
Ocugen EBITDA Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Dec 22 | Mar 22 | Mar 21 | |
|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 4 | 1 | 1 | 1 | 1 |
| EBITDA | - | - | - | - | - | - | - | $-24.15M | $-17.96M | $-7.01M |
| Avg Forecast | $-227.20K | $-227.20K | $-227.20K | $-227.20K | $-80.00K | $-80.00K | $-228.20K | $-433.33K | $-2.77M | $-13.13M |
| High Forecast | $-227.20K | $-227.20K | $-227.20K | $-227.20K | $-80.00K | $-77.19K | $-228.20K | $-433.33K | $-2.77M | $-10.50M |
| Low Forecast | $-227.20K | $-227.20K | $-227.20K | $-227.20K | $-80.00K | $-84.21K | $-228.20K | $-433.33K | $-2.77M | $-15.75M |
| Surprise % | - | - | - | - | - | - | - | 55.73% | 6.48% | 0.53% |
undefined analysts predict OCGN's average Quarter EBITDA for undefined to be $NaN, with a high of $NaN and a low of $NaN. This is NaN% lower than Ocugen's previous annual EBITDA (undefined) of $NaN.
Ocugen Net Income Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Dec 22 | Mar 22 | Mar 21 | |
|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 4 | 1 | 1 | 1 | 1 |
| Net Income | - | - | - | - | - | - | - | $-19.73M | $-18.00M | $-7.08M |
| Avg Forecast | $-19.47M | $-18.08M | $-18.08M | $-16.69M | $-15.30M | $-15.30M | $-13.73M | $-27.82M | $3.43M | $-13.25M |
| High Forecast | $-19.47M | $-18.08M | $-18.08M | $-16.69M | $-12.75M | $-12.75M | $-13.73M | $-27.82M | $3.43M | $-10.60M |
| Low Forecast | $-19.47M | $-18.08M | $-18.08M | $-16.69M | $-15.30M | $-17.85M | $-13.73M | $-27.82M | $3.43M | $-15.90M |
| Surprise % | - | - | - | - | - | - | - | 0.71% | -5.25% | 0.53% |
Ocugen's average Quarter net income forecast for undefined is $NaN, with a range of $NaN to $NaN. OCGN's average Quarter net income forecast represents a NaN% decrease compared to the company's last Quarter net income of $NaN (undefined).
Ocugen SG&A Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Dec 22 | Mar 22 | Mar 21 | |
|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 4 | 1 | 1 | 1 | 1 |
| SG&A | - | - | - | - | - | - | - | $6.94M | $10.12M | $4.18M |
| Avg Forecast | $47.37M | $47.37M | $47.37M | $47.37M | $16.68M | $16.68M | $47.58M | $90.35M | $578.27M | $7.83M |
| High Forecast | $47.37M | $47.37M | $47.37M | $47.37M | $16.68M | $17.56M | $47.58M | $90.35M | $578.27M | $9.40M |
| Low Forecast | $47.37M | $47.37M | $47.37M | $47.37M | $16.68M | $16.10M | $47.58M | $90.35M | $578.27M | $6.27M |
| Surprise % | - | - | - | - | - | - | - | 0.08% | 0.02% | 0.53% |
Ocugen's average Quarter SG&A projection for Jun 24 is $47.58M, based on 1 Wall Street analysts, with a range of $47.58M to $47.58M. The forecast indicates a 585.91% rise compared to OCGN last annual SG&A of $6.94M (Dec 22).
Ocugen EPS Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Dec 22 | Mar 22 | Mar 21 | |
|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 4 | 1 | 1 | 1 | 1 |
| EPS | - | - | - | - | - | - | - | $-0.09 | $-0.09 | $-0.04 |
| Avg Forecast | $-0.07 | $-0.07 | $-0.07 | $-0.06 | $-0.06 | $-0.06 | $-0.05 | $-0.10 | $0.01 | $0.19 |
| High Forecast | $-0.07 | $-0.07 | $-0.07 | $-0.06 | $-0.05 | $-0.05 | $-0.05 | $-0.10 | $0.01 | $0.19 |
| Low Forecast | $-0.07 | $-0.07 | $-0.07 | $-0.06 | $-0.06 | $-0.06 | $-0.05 | $-0.10 | $0.01 | $0.19 |
| Surprise % | - | - | - | - | - | - | - | 0.90% | -6.56% | -0.21% |
According to undefined Wall Street analysts, Ocugen's projected average Quarter EPS for undefined is $NaN, with a low estimate of $NaN and a high estimate of $NaN. This represents a NaN% decrease compared to OCGN previous annual EPS of $NaN (undefined).